Search research articles
Contact Us
Filters
Showing results (1-10 of 180) with videos related to
Page
of 18
Sort By:
Global & Regional Health Technology Assessment
|
April 11, 2024
The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example
Mickaël Hiligsmann, Olivier Bruyère
Best Practice & Research. Clinical Endocrinology & Metabolism
|
November 30, 2014
The application of health technology assessment in osteoporosis
John A Kanis, Mickaël Hiligsmann
Pharmacoeconomics
|
June 23, 2011
Cost effectiveness of denosumab compared with oral bisphosphonates in the treatment of post-menopausal osteoporotic women in Belgium
Mickaël Hiligsmann, Jean-Yves Reginster
Bone
|
March 23, 2010
Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women
Mickaël Hiligsmann, Jean-Yves Reginster
International Journal of Technology Assessment in Health Care
|
September 25, 2018
EARLY DIALOGUE IN EUROPE: PERSPECTIVES ON VALUE, CHALLENGES, AND CONTINUING EVOLUTION
Lina Balaisyte, Angelika Joos, Mickaël Hiligsmann
International Journal of Technology Assessment in Health Care
|
February 24, 2021
Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements
Hannah Sievers, Angelika Joos, Mickaël Hiligsmann
The Annals of Thoracic Surgery
|
April 25, 2023
Economic Evaluation of Endoscopic vs Open Vein Harvesting
Hannah Eckey, Sophie Heseler, Mickaël Hiligsmann
International Journal of Technology Assessment in Health Care
|
May 22, 2023
Stakeholder perspectives on cooperation in the clinical and nonclinical health technology assessment domains
Gina Zimmermann, Sandra Michelmore, Mickaël Hiligsmann
Journal of Medical Economics
|
March 30, 2022
Economic evaluation of a JAK inhibitor compared to a monoclonal antibody for treatment of moderate-to-severe atopic dermatitis from a UK perspective
Katja C Heinz, Damon Willems, Mickaël Hiligsmann
Bone
|
September 1, 2009
Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years
Mickaël Hiligsmann, Olivier Bruyère, Jean-Yves Reginster
Page
of 18
Search research articles
Search
Showing results (1-10 of 180) with videos related to
Sort By:
Page
of 18
Global & Regional Health Technology Assessment
|
April 11, 2024
The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example
Mickaël Hiligsmann, Olivier Bruyère
Best Practice & Research. Clinical Endocrinology & Metabolism
|
November 30, 2014
The application of health technology assessment in osteoporosis
John A Kanis, Mickaël Hiligsmann
Pharmacoeconomics
|
June 23, 2011
Cost effectiveness of denosumab compared with oral bisphosphonates in the treatment of post-menopausal osteoporotic women in Belgium
Mickaël Hiligsmann, Jean-Yves Reginster
Bone
|
March 23, 2010
Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women
Mickaël Hiligsmann, Jean-Yves Reginster
International Journal of Technology Assessment in Health Care
|
September 25, 2018
EARLY DIALOGUE IN EUROPE: PERSPECTIVES ON VALUE, CHALLENGES, AND CONTINUING EVOLUTION
Lina Balaisyte, Angelika Joos, Mickaël Hiligsmann
International Journal of Technology Assessment in Health Care
|
February 24, 2021
Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements
Hannah Sievers, Angelika Joos, Mickaël Hiligsmann
The Annals of Thoracic Surgery
|
April 25, 2023
Economic Evaluation of Endoscopic vs Open Vein Harvesting
Hannah Eckey, Sophie Heseler, Mickaël Hiligsmann
International Journal of Technology Assessment in Health Care
|
May 22, 2023
Stakeholder perspectives on cooperation in the clinical and nonclinical health technology assessment domains
Gina Zimmermann, Sandra Michelmore, Mickaël Hiligsmann
Journal of Medical Economics
|
March 30, 2022
Economic evaluation of a JAK inhibitor compared to a monoclonal antibody for treatment of moderate-to-severe atopic dermatitis from a UK perspective
Katja C Heinz, Damon Willems, Mickaël Hiligsmann
Bone
|
September 1, 2009
Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years
Mickaël Hiligsmann, Olivier Bruyère, Jean-Yves Reginster
Page
of 18